Long-acting injectable antipsychotics: A useful and well tolerated option in elderly patients with psychotic illnesses

Drugs and Therapy Perspectives

Volumn 20, Issue 12, 2004, Pages 7-10

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; HALOPERIDOL DECANOATE; LONG ACTING DRUG; NEUROLEPTIC AGENT; PIPOTIAZINE; PLACEBO; RISPERIDONE; ZUCLOPENTHIXOL;

AGED; AKATHISIA; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT DISORDER; BRADYCARDIA; BRONCHITIS; CLINICAL TRIAL; CONSTIPATION; DELUSIONAL DISORDER; DEMENTIA; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DISPOSITION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; ECG ABNORMALITY; EXTRAPYRAMIDAL SYMPTOM; GERIATRIC PATIENT; HALLUCINATION; HOSPITALIZATION; HUMAN; HYPOTENSION; INSOMNIA; LONG TERM CARE; LOW DRUG DOSE; MOOD DISORDER; MOTOR DYSFUNCTION; OPTIMAL DRUG DOSE; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; PSYCHOSIS; RELAPSE; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SYMPTOM; TARDIVE DYSKINESIA;

EID: 10944251681     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-200420120-00003     Document Type: Article

References (19)

1. Masand PS, Gupta S. Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Drugs Aging 2003; 20 (15): 1099-110
2. Jeste DV, Alexopoulos GS, Bartels SJ, et al. Consensus statement on the upcoming crisis in geriatric mental health. Arch Gen Psychiatry 1999; 56: 848-53.
3. Vergouwen AC, Bakker A, Koerselman F. Adherence to medication for chronic psychiatric diseases: determining the optimum frequency and form of administration. Am J Drug Deliv 2003; 1 (4): 267-73
4. Kane JM. Dosing issues and depot medication in the maintenance treatment of schizophrenia. Int Clin Psychopharmacol 1995; 10 Suppl. 3: 65-71
5. Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia: European Neuropsychopharmacology Consensus Conference in Sienna, Italy. Eur Neuropsychopharmacol 1998; 8: 55-66
6. Glazer WM, Kane JM. Depot neuroleptic therapy: an underutilized treatment option. J Clin Psychiatry 1992; 53: 426-33
7. Walburn J, Gray R, Gournay K, et al. Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry 2001; 179: 300-7
8. Savatovic M, Madhusoodanan S, Buckley P. Schizophrenia in the elderly: guidelines for management. CNS Drugs 2000; 13: 103-15
9. Altamura AC, Mauri MC, Girardi T, et al. Clinical and toxilogical profile of fluphenazine in elderly chronic schizophrenia. Int J Clin Pharmacol Res 1990; 10 (4): 223-8
10. Finkel SI. Antipsychotics: old and new. Clin Geriatr Med 1998; 14: 87-100
11. Raskind M, Alvarez C, Herlin S. Fluphenazine enanthate in the treatment of late paraphrenia. J Am Geriatr Soc 1979; 27: 459-63
12. Howard R, Levy R. Which factors affect treatment response in late paraphrenia? Int J Geriatr Psychiatry 1992; 7: 667-72
13. Jeste DV, Caligiuri MP, Paulsen JS, et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 1995 Sep; 52: 756-65
14. Jeste DV, Lacro JP, Bailey A, et al. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999; Jun 47 (6): 716-9
15. Csernansky JG, Mahmoud R, Brenner R, et al. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 2002; 346: 16-22
16. Kane JM, Eerdekens M, Lindenmayer JP, et al. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry 2003; 160 (6): 1125-32
17. Fleishchacker WW, Eerdekens, Xie Y, et al. Long-term efficacy and safety of Risperdal Consta, a long-acting injection formulation of risperidone [poster]. 40th Annual Meeting of the American College of Neuropsychopharmacology; 2001 Dec 9-13; Waikoloa, Hawaii
18. British National Formulary. No. 47. London: The Pharmaceutical Press, 2004 Mar
19. Masand PS. Side effects of antipsychotics in the elderly. J Clin Psychiatry 2000; 61 Suppl. 8: 43-9